SMB01067

Angeloylgomisin H

≥90% (LC/MS-ELSD)

• Synonim(y): (+)-Angeloylgomisin H, tigloylgomisin H
• Wzór empiryczny (zapis Hilla): C₂₈H₃₆O₈
• Numer CAS: 66056-22-2
• Masa cząsteczkowa: 500.58
• UNSPSC Code: 12352205
• NACRES: NA.25

Właściwości

• biological source: plant
• assay: ≥90% (LC/MS-ELSD)
• form: solid
• mol wt: 500.58
• application(s): metabolomics; vitamins, nutraceuticals, and natural products
• storage temp.: −20°C
• SMILES string: OC1(C(Cc2c(c(c(c(c2)OC)OC)OC(=O)C(=CC)C)c3c(cc(c(c3OC)OC)OC)C1)C)C
• InChI: 1S/C28H36O8/c1-10-15(2)27(29)36-26-21-17(12-19(31-5)24(26)34-8)11-16(3)28(4,30)14-18-13-20(32-6)23(33-7)25(35-9)22(18)21/h10,12-13,16,30H,11,14H2,1-9H3
• InChI key: ZSAUXCVJDYCLRS-UHFFFAOYSA-N

Opis

General description

Angeloylgomisin H, a lignan, is a natural product commonly found in the fruits of Schisandra chinensis and the roots of Angelica Dahurica. This compound exhibits potent biological activity, including anti-inflammatory, antioxidant, antidiabetic, antiproliferative, and anticancer properties.

Application

It is a natural product derived from plant source that finds application in screening, metabolomics, phytochemical and pharmaceutical research.

Biochem/physiol Actions

• Inhibits the activity of enzymes involved in carcinogenic metabolism, such as ornithine decarboxylase and acetylcholinesterase.
• Facilitates the detoxification of specific carcinogens, including benzo(a)pyrene, by converting them into non-toxic metabolites.
• Exhibits anti-diabetic effects, potentially linked to its capacity to stimulate insulin release.

Features and Benefits

• High quality compound suitable for multiple research applications
• Compatible with HPLC and mass spectrometry techniques

Other Notes

For additional information on our range of Biochemicals, please complete this form.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable